GLP-1 Receptor Agonists.
www.nejm.org/doi/full/10....
@nejm.org
#CardioSky #MedSky #Cardiology #EndoSky #GLP1RA
1
1
0
0
Hashtag
#GLP1RA
Advertisement · 728 × 90
📚 In this retrospective cohort study, GLP1-RA use was not associated with increased risk of pneumonia or other procedure-related complications among patients undergoing gastrointestinal endoscopy.
🔗 https://ow.ly/BnIv50YxQZq
🏷️ #GLP1RA
0
0
0
0
JAMA Cardiology presents "Oral Glucagon-Like Peptide-1 Therapies—Moving Beyond Needles," an Editor's Note by Sadiya S. Khan, MD, MSc1,2. Published online March 25, 2026. DOI: 10.1001/jamacardio.2026.0261. Includes links to author affiliations and article information.
💬 Editor's Note: Oral #GLP1RA therapies offer new options for cardiovascular risk reduction, supporting shared decision-making for patients and clinicians as the landscape evolves beyond injectable agents.
ja.ma/4dHrVRK
0
0
0
0
Sankey diagram showing medication switches. Semaglutide (Wegovy) 45 098 (35.5%), Semaglutide (Ozempic) 34 828 (27.4%), Liraglutide (Saxenda) 26 384 (20.8%), Tirzepatide 9866 (7.8%), Semaglutide (Rybelsus) 4619 (3.6%), Dulaglutide 4438 (3.5%).
Among adults with overweight or obesity, <25% remained on a #GLP1RA at 12 months. Switching agents was common and linked to higher persistence and adherence than remaining on one agent.
ja.ma/4sCgu1W
1
3
0
0
GLP-1RA producen una mayor pérdida del peso en las mujeres que en los hombres, con efectos consistentes en otras subpoblaciones #GLP1RA #sex jamanetwork.com/journals/jam...
0
0
0
0
Iniciar terapia con GLP-1RA en adultos mayores con diabetes tipo 2 se asocia con un riesgo moderadamente mayor de fracturas por fragilidad #GLP1RA #fractures academic.oup.com/jcem/article...
0
0
0
0
Kaplan-Meier curves compare the hazard of new chronic cough over time with Glucagon-Like Peptide-1 Receptor Agonist(GLP-1 RA). The graphs show cumulative incidence vs time for GLP1-RA against non-GLP1 receptor agonist,DPP-4 inhibitors,SGLT2 inhibitors and Sulfonylureas.
Use of glucagon-like peptide-1 receptor agonists (#GLP1RA) in adults with type 2 #diabetes was associated with an increased risk of new chronic cough compared with other second-line diabetes medications.
bit.ly/4koi9We
1
1
0
0
For patients with endometrial hyperplasia or benign uterine pathology, receiving progestin in combination with #GLP1RA therapy is associated with a reduced risk of #endometrialCancer. Published in @jamanetworkopen.com.
https://bit.ly/4bOhdrR
#gyncsm #GLP1
0
0
0
0
Real-world data presented at #CCCongress26 suggest #GLP1 RAs may benefit #CrohnsDisease patients with overweight/obesity. #GLP1RA use was linked to lower steroid dependence, fewer hospitalizations, and improved durability of advanced IBD therapy. #IBDSky #GISky
0
0
0
0
Usuarios recientes de SGLT2i tienen un riesgo modestamente menor de enfermedad del pie principalmente por un menor riesgo de neuropatía que los que usan GLP-1RA #foot #SGLT2i #GLP1RA www.acpjournals.org/doi/10.7326/...
0
0
0
0
The use of GLP-1 receptor antagonist therapy has led to a greater reduction in #colorectalcancer incidence than has been observed with aspirin. Presented at #GI26.
https://bit.ly/45jGd6a
#crcsm #GLP1RA
0
0
0
0
#MedNews - Use of incretin-based therapies may reduce the risk for alcohol use disorder in people who undergo Roux-en-Y gastric bypass or sleeve gastrectomy.
Full story 👉 buff.ly/tMu2y5R
#GLP1RA #BariatricSurgery
1
0
0
0
Three graphs show FM loss (A), FFM loss (B), and FFM to FM ratio (C) over time in months. Each graph compares "Surgery" and "GLP-1RA" treatments. Surgery shows higher FM loss and FFM to FM ratio but lower FFM loss compared to GLP-1RA.
Over 2 years, both bariatric surgery and #GLP1RA treatment were associated with substantial fat mass loss, moderate fat-free mass loss, and increased FFM/FM ratio, with changes more pronounced after surgery. ja.ma/3YQSXxH
1
0
0
0
Caregivers with #FoodInsecurity weighing #GLP1RA use for children with #Obesity cited experiences with lifestyle change, trust in medication safety, and personal values as central to treatment decisions. ja.ma/49l47PJ
0
0
0
0
GLP-1RAs in Neuroendocrine Tumors: The Scientists and the Clinicians Conundrums | Join us on Monday, January 12 at 5:00 PM ET to explore the emerging evidence on GLP-1 receptor agonist use in patients with neuroendocrine tumors: https://bit.ly/414QXRB #endocrinology #GLP1RA
0
0
0
0
Diabetes drug boost? Review links GLP-1RAs to miRNA changes—improves T2DM outcomes. #Type2Diabetes #GLP1RA
www.rimpacts.com/rd/p?c=10039... 📄DOI: doi.org/10.1186/s129...
2
0
0
0
JAMA Network Open Research Letter: Glucagonlike Peptide-1 Receptor Agonists and Asthma Risk in Adolescents With Obesity. By Yung-Chieh Huang, Ming-Chin Tsai, and Tim C. C. Lin. Published December 29, 2025.
This retrospective cohort study reported an association between #GLP1RA use and a lower risk of acute #asthma exacerbations in adolescents with #overweight or #obesity, suggesting a potential dual benefit for this population. ja.ma/4aImOQ1
1
0
0
0
🎉Our new research shows that #GLP1RA use at #ICI initiation is associated with lower mortality, fewer hospitalizations, and fewer immune-related adverse events in individuals with cancer and T2D.
www.sciencedirect.com/science/arti...
0
0
0
0
A #FIDELITY Analysis on #Finerenone With #SGLT2i and #GLP1RA in CKD
#VisualAbstract by Cristina Popa
www.kireports.org/article/S2468-0249(25)00...
3
1
0
0
🎉Our new research shows that #GLP1RA use at #ICI initiation is associated with lower mortality, fewer hospitalizations, and fewer immune-related adverse events in individuals with cancer and T2D.
www.sciencedirect.com/science/arti...
1
0
0
0
🎊Our new research shows pre-transplant #GLP1RA + #SGLT2i therapy is associated with lower post-transplant mortality, fewer graft failures, and complications in organ transplant candidates with obesity and T2D. advanced.onlinelibrary.wiley.com/doi/full/10....
1
0
0
0
En pacientes con diabetes tipo 2, los GLP-1RA y los DPP-4i se asocian con un pequeño aumento en el riesgo de enfermedad biliar pero no de pancreatitis aguda, comparados con los SGLT2i #SGLT2is #GLP1RA #dpp4i #t2d diabetesjournals.org/care/article...
0
0
0
0
Excited to share our new work using real world data and a target trial emulation to evaluate pre transplant dual therapy with #GLP1RA plus #SGLT2i in solid organ transplant candidates with #Obesity and #Type2Diabetes
advanced.onlinelibrary.wiley.com/doi/10.1002/...
0
0
0
0
0
0
0
0
En mujeres con obesidad, uso de GLP-1RA c/suspensión antes del embarazo o a principios del embarazo se asocia con más aumento del peso gestacional y mayor riesgo de parto pretérmino, diabetes gestacional y de trastornos hipertensivos del embarazo #pregnancy #GLP1RA jamanetwork.com/journals/jam...
0
0
0
0
GLP-1 receptor agonists reduce body mass index and total daily insulin dose in youth with type 1 diabetes: a retrospective cohort study.
Chao, Lily C et al.
Paper
Details
#Type1Diabetes #GLP1RA #YouthHealth
0
0
0
0
En pac c/diabetes tipo 2, TTO dual c/metformina y GLP-1RA se asocia c/incidencia 39% menor de neoplasias asoc c/adiposidad y mortalidad 67% menor, con un impacto notable sobre las variables relacionadas con el cáncer #T2D #metformin #GLP1RA #Cancer dom-pubs.onlinelibrary.wiley.com/doi/10.1111/...
0
0
0
0
Uso de agonistas del receptor del péptido 1 semejante a glucagon se asocia con tos crónica #GLP1RA #chroniccough jamanetwork.com/journals/jam...
0
0
0
0
Kaplan-Meier curves show the hazard of new chronic cough over time comparing GLP-1 RA with non-GLP-1 RA, DPP4, SGLT2 inhibitors, and sulfonylureas. Each graph plots 'Cumulative incidence of new chronic cough, %' against 'Time, d'. GLP1-RA shown with the other inhibitors.
Use of glucagon-like peptide-1 receptor agonists (#GLP1RA) in adults with type 2 #diabetes was associated with an increased risk of new chronic cough compared with other second-line diabetes medications.
ja.ma/3LZtgrs
0
0
0
0
